Results 161 to 170 of about 8,923 (197)

Fiber density in acute and chronic inflammatory demyelinating polyneuropathy

Muscle & Nerve, 1992
AbstractThe fiber density in the deltoid, extensor digitorum communis, and first dorsal interosseous muscles was measured using SFEMG in 11 patients with acute and chronic inflammatory demyelinating polyneuropathy. The fiber density was increased in 58% of the muscles studied. The deltoid muscle was the most abnormal of the 3 muscles studied. There was
M, Gantayat, M, Swash, M S, Schwartz
openaire   +2 more sources

Acute clinical onset chronic inflammatory demyelinating polyneuropathy in a dog

Muscle and Nerve, 2011
AbstractWe report a case of acute‐onset ambulatory paraparesis with electrophysiological abnormalities compatible with axonal and demyelinating lesions in a Rottweiler dog. Although the clinical findings were compatible with acute canine idiopathic polyneuropathy, postmortem investigations revealed a chronic demyelinating polyneuropathy affecting the ...
Jessica Molin, Kaspar Matiasek, I Ferrer   +2 more
exaly   +3 more sources

Perineurium contributes to axonal damage in acute inflammatory demyelinating polyneuropathy

Neurology, 2000
To assess if axonal damage in severe acute inflammatory demyelinating polyneuropathy (AIDP) correlates with the appearance of epiperineurium in nerve trunks.Increase of endoneurial fluid pressure in nerve trunks possessing epiperineurium may be an important mechanism of axonal damage in AIDP.A 79-year-old man had a 2-day history of acroparesthesias and
J, Berciano, A, García, J, Figols, R, Muñoz, M T, Berciano, M, Lafarga   +5 more
openaire   +2 more sources

A Case of Mercury Toxicity Complicated by Acute Inflammatory Demyelinating Polyneuropathy

Journal of Child Neurology, 2018
A 13-year-old African American male presented with 2 months of subacute altered mental status, ptosis, areflexia, disordered gait, constipation, weight loss, abdominal and testicular pain, and hyperhidrosis. Initial workup at our facility was unrevealing until elevated serum mercury level was detected.
Stacey, Evans, Jeffrey, Smith, Elena, Caron   +2 more
openaire   +2 more sources

Acute inflammatory demyelinating polyneuropathy (Guillain—Barré syndrome)

Russian Journal of Archive of Pathology
Guillain—Barré syndrome is an acute immune-mediated polyradiculoneuropathy, which is the most common cause of acute paralysis and requires intensive therapy in one third of cases. Considering the fact that the disease is rare and characterized by low mortality, morphological changes in it are described rather modestly, based on isolated examples.
V.V. Swistunov, E.I. Dzhoga
openaire   +2 more sources

Early differential diagnosis between acute inflammatory demyelinating polyneuropathy and acute-onset chronic inflammatory demyelinating polyneuropathy in children: Clinical factors and routine biomarkers

European Journal of Paediatric Neurology
To identify clinical factors and biomarkers that could contribute to early differential diagnosis of acute inflammatory demyelinating polyneuropathy (AIDP) and acute-onset chronic inflammatory demyelinating polyneuropathy (A-CIDP) in the pediatric population, with limited evidence.We conducted an observational retrospective study of children diagnosed ...
Jiannan Ma, Li Jiang
exaly   +3 more sources

Association of acute inflammatory demyelinating polyneuropathy with acute lymphoblastic leukaemia and HLA-A11

Journal of Clinical Neuroscience, 1998
Acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome) developed in three patients receiving chemotherapy for acute lymphoblastic leukaemia or the closely related entity lymphoblastic lymphoma, a relationship that has not been previously described.
A, Grigg, B, Tait, S, Davis, L, Kiers
openaire   +2 more sources

A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies

Muscle & Nerve, 1987
AbstractAcute and chronic inflammatory demyelinating neuropathies are among the most common treatable neuropathies seen by neurologists. Evidence for effective therapy has only recently been provided by randomized or controlled trials. In the Guillain‐Barré syndrome such evidence does not support the use of corticosteroids or immunosuppressive agents ...
openaire   +2 more sources

[Autonomic dysfunction in acute inflammatory demyelinating polyneuropathy].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2005
Acute inflammatory demyelinating polyneuropathy (AIDP) is an autoimmune process that is characterized by progressive weakness, mild sensory changes and autonomic dysfunction. It is a rare disorder, afflicting about 1 person in 100,000. Yet, since the decline in the number of polio cases, it represents the most common cause of acute neuromuscular ...
D, Cuciureanu, Rodica, Prodan
openaire   +1 more source

Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy

Annals of Neurology, 1996
AbstractThe localization, mode of action, and roles of complement in the Guillain‐Barré syndrome have been controversial. We used high‐resolution immunocytochemistry to localize complement activation products in early stages of the acute inflammatory demyelinating polyneuropathy (AIDP) pattern of Guillain‐Barré syndrome.
C E, Hafer-Macko, K A, Sheikh, C Y, Li, T W, Ho, D R, Cornblath, G M, McKhann, A K, Asbury, J W, Griffin   +7 more
openaire   +2 more sources